In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Cerus Corp (NASDAQ:CERS) reported that Elk Creek Partners, Llc. has picked up 5,369,931 of common stock as of 2017-05-08.
The acquisition brings the aggregate amount owned by Elk Creek Partners, Llc. to a total of 5,369,931 representing less than 5.17% stake in the company.
For those not familiar with the company, Cerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment. The Company’s INTERCEPT Blood System is based on its technology for controlling biological replication, and is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The Company’s INTERCEPT Blood System is designed to target and inactivate blood-borne pathogens, such as viruses, including human immunodeficiency virus (HIV), West Nile, Severe acute respiratory syndrome (SARS), hepatitis B and C; bacteria and parasites, as well as harmful white blood cells, while preserving the therapeutic properties of platelet, plasma and red blood cell transfusion products. The Company’s INTERCEPT Blood System is for use with blood components, including plasma, platelets, and red blood cells.
A glance at Cerus Corp (NASDAQ:CERS)’s key stats reveals a current market capitalization of 320.87 Million based on 103.94 Million shares outstanding and a price at last close of $3.25 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-08-20, Corash picked up 19,500 at a purchase price of $4.95. This brings their total holding to 1,289,756 as of the date of the filing.
On the sell side, the most recent transaction saw Moore unload 2,377 shares at a sale price of $4.15. This brings their total holding to 25,583.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Cerus Corp (NASDAQ:CERS) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.